EBITDA Ratio. Ratio of EBITDA to the preceding twelve (12) months interest expense plus the projected maturities of long-term debt for the next succeeding twelve months on a rolling basis, of not less than 1.25:1.00, to be measured annually. Debt/Tangible Net Worth. Maximum of 4.00:1.00, to be measured annually. Limitation on Loans and Advances to Owners. Not to exceed $500,000 per calendar year.
EBITDA Ratio. Maintain, as of the end of each fiscal year, an EBITDA Ratio of not less than 1.25 to 1.0.
EBITDA Ratio. The BORROWERS, on a consolidated basis, shall maintain a ratio of (a) EBITDA to (b) INTEREST EXPENSE plus the total amount of cash payments of principal on account of LONG TERM DEBT, of greater than 1.00:1.00, measured semi-annually on a year-to-date basis at December 31 and June 30 of each year commencing as of December 31, 2005.
EBITDA Ratio. Osteotech, Inc. is not to cause or permit any of the following:
EBITDA Ratio. An EBITDA Ratio of not less than:
EBITDA Ratio. As of the end of each calendar month, an EBITDA Ratio of not less than (i) 1.00 to 1.00 commencing with the calendar month ending December 31, 2016 through and including September 30, 2017, (ii) 1.25 to 1.00 commencing with the calendar month ending October 31, 2017 through and including November 30, 2017, (iii) 1.50 to 1.00 commencing with the calendar month ending December 31, 2017 through and including November 30, 2018 and (iv) 1.75 to 1.00 commencing with the calendar month ending December 31, 2018 and thereafter.
EBITDA Ratio. A ratio of Obligations to EBITDA, to be tested as of the last day of each quarter, on an annualized basis, of no greater than 2.0 to 1.0."
